| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 . 460 . 470 . 480 . 490 . 500 . 510 . 520 . 530 . 540 . 550 . 560 . 570 . 580 . 590 . 600 . 610 . 620 . 630 . 640 . 650 . 660 . 670 . 680 . 690 . 700 . 710 . 720 . 730 . 740 . 750 . 760 . 770 . 780 . 790 . 800 . 810 . 820 . 830 . 840 . 850 . 860 . 870 . 880 . 890 . 900 . 910 . 920 |
# |
Score |
Template |
Links and tools | %id | First |
MDHRAQAREVFVRAQLEAVQKAITKNEVPLKPKHARTIIVGTHKEKSSGIFWHTVGRIQLEKHPVLTWKFCHLVHKLLRDGHRKVPEETYRYVNRFTQLSQFWKHLNTSGYGPCIESYCKLLHDRVTFHNKYPVVPGKLDLNDSQLKTLEGDLDNMFEMTIDMLDQMDALLVLQDRVYEMMNSLRWNSLIPQGQCMLSPLIIAILDTSKFYDYLVKMIFKLHSQVPPDALEGHRSRFRTIFERTKKFYEESSNLQYFKYLVSIPTLPSHAPNFLQQSDLESYRTPHAYLHSEGSEDGTSLNGHDGELLNLAEAEPQQASPSSQPDPREEQIVMLSRAVEDEKFAKERLIQEARSRIEQYENRLLQMQGEFDHAKREADENREEAQRLKNELALRDASRTQTDDARVKEAELKATAAEERFNKMKGVYEKFRSEHVLALTKLGDIQKQLEASEKSKFDKDEEITALNRKVEEAQREAGRALTKAEGDAGAVDEMRTQLVKADIEVEELKRTIDHLRESHANQLVQSSAEETNKIRLAELEVAKESGVGITQMFDHCEDALQNATSITYPPHLAQSAMNNLVNILSNERLDEPLATKDNVFAGHLLSTTLSAAASAAYTASIESYEGVNDQCKKVLAAAKVAFSDDSALSRADKMKLLRQDIQTLNSLMISLPLQTDIDKDVVGNELEQEMRRMDDAIRRAVQEIEAIQRRARESSDGIRLEVNESILANCQALMSVIMQLVIASRELQTEIVAAGKAGGSPAEFYKRNHQWTEGLLSAAKAVGVAARVLVESADGVVTGKGKFEHLIVAAQEIAASTAQLFVSSRVKADKDSSKLDALSVAAKAVNQNTAQVVAAVKNGQTTLNDEGSLDFSYLSLHAAKKEEMESQVKMLELEQSLNQERAKLAALRKQHYHMAQLVANKS | Last |
1 | -212.000 | [Z] KOG0980 Actin-binding protein SLA2/Huntingtin-interacting protein Hip1 |
ali |
100 | 1 | MDHRAQAREVFVRAQLEAVQKAITKNEVPLKPKHARTIIVGTHKEKSSGIFWHTVGRIQLEKHPVLTWKFCHLVHKLLRDGHRKVPEETYRYVNRFTQLSQFWKHLNTSGYGPCIESYCKLLHDRVTFHNKYPVVPGKLDLNDSQLKTLEGDLDNMFEMTIDMLDQMDALLVLQDRVYEMMNSLRWNSLIPQGQCMLSPLIIAILDTSKFYDYLVKMIFKLHSQVPPDALEGHRSRFRTIFERTKKFYEESSNLQYFKYLVSIPTLPSHAPNFLQQSDLESYRTPHAYLHSEGSEDGTSLNGHDGELLNLAEAEPQQASPSSQPDPREEQIVMLSRAVEDEKFAKERLIQEARSRIEQYENRLLQMQGEFDHAKREADENREEAQRLKNELALRDASRTQTDDARVKEAELKATAAEERFNKMKGVYEKFRSEHVLALTKLGDIQKQLEASEKSKFDKDEEITALNRKVEEAQREAGRALTKAEGDAGAVDEMRTQLVKADIEVEELKRTIDHLRESHANQLVQSSAEETNKIRLAELEVAKESGVGITQMFDHCEDALQNATSITYPPHLAQSAMNNLVNILSNERLDEPLATKDNVFAGHLLSTTLSAAASAAYTASIESYEGVNDQCKKVLAAAKVAFSDDSALSRADKMKLLRQDIQTLNSLMISLPLQTDIDKDVVGNELEQEMRRMDDAIRRAVQEIEAIQRRARESSDGIRLEVNESILANCQALMSVIMQLVIASRELQTEIVAAGKAGGSPAEFYKRNHQWTEGLLSAAKAVGVAARVLVESADGVVTGKGKFEHLIVAAQEIAASTAQLFVSSRVKADKDSSKLDALSVAAKAVNQNTAQVVAAVKNGQTTLNDEGSLDFSYLSLHAAKKEEMESQVKMLELEQSLNQERAKLAALRKQHYHMAQLVANKS |
921 |
2 | -39.100 | [TU] KOG0251 Clathrin assembly protein AP180 and related proteins, contain ENTH domain |
ali follow.. |
15 | 1 | MGTLQSWRNSEYADLDVAIVKATNHVECPPKDRHLRKIFAATSVTRAAYCIHALSRRLHKTRNWTVALKTLIVIHRLLREGDPTFREELFSQRGRILQLSNF-SSPIAWDCSAWVRTYALFLEERLECFRVLKYD---TEAERLPKSNPGQDKGYSRTRDLDGEELLEQLPALQQLLYRLIGCRPEGAAN-HNHVIQYALALVLKESFKVYCNLIDKFFEMAKHEAITSLEIYK-RAGQQARSLSDFYEACKGLELARN-FQFPVLREPPQSFLTTMEEYIKEAPRVVDVPAEPLLLTYRPDDGLTTEDTEPSHEEREMLPSDDVVVVSEETEPSPPPPPSANAQNFIDTDDLWGLNTGAPDTSVIEDQ........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
395 |
3 | -16.800 | [U] KOG4809 Rab6 GTPase-interacting protein involved in endosome-to-TGN transport |
ali follow.. |
11 | 169 | ..................................................................................................................................................................................................................................RKDVEVKESKLSSSMNSIKTFWS--------------PELKKE------RKDEASKITIWKEQYRVVQEENQHMQMTIQALQDELRIQRDLNQLFQQDSSSRTGEPCVAELTEENFQRLHAEHERQAKELFLLRKTLEEMELRIETQKQTLNARDESIKKLLEMLQSKGLFENAPDSAKTKALQTVIEMKDSKISSMERGLRDLEEEIQMLKSNGALSTEEREEEMKQMEVYRSHSKFMKNKIGQVKQELSRKDTELLALQTKLETLTNQFSDSKQHIEVLKESLTAKEQRAAILQTEVDALRLR---EEKETMLNKKTKQIQDMAEEKGTQAGEIHDLKDMLDVKERKVNVLQKKIENLQEQLRDKEKQMSSLKERVKSL--QADTTNTDTALTTLEEALAEKERTIERLKEQRDR-DEREKQEEIDNYKKDLKDLKEKVSLLQGDLSEKEASLLDLKDSRLKTLEIALEQKKEECLKMESQLKKAHEAALARASPEMSDRIQHLEREITRYKDESSKAQAEV----------DRLLEILKEVENEKNDKDKKIAELESLTSRQVKDQNKKVANLKH---KEQVEKKKSAQMLEEARRREDNLNELLMAMEKVKQELESMKAKLSSTQQSLAEKETHLTNLR-MKQEALLAAISEKDANIALLELSSSKKKTQEEVAALKREKDRLVQQLKQQT |
908 |
4 | -13.100 | [S] COG5283 Phage-related tail protein |
ali follow.. |
9 | 2 | .............................................................................................................................................................................................................................................................................................................................................ADIMVDSVTTGIDLNETKAVEAINRLKSAVKDSTREWQINEAQAKSAGDAVSASK---------------YRYEGLSEAMEKQKAYIANLSEGMKTINRNTDAGEKAYQKYNAQLTTAERSLASMTGQLNRAKSAYEYQQTGIEDLNKSLSANDKLMQSQIDLYEKTRNKMGAAKAEVSGLSTSYAKQTEIYRAQVTE-------KRLEAAEGTSSETLVKQKTRVNEAASS---------------------------LMNYRNKLLEANLAVTKMQPFNSESLIGKGLNTVYQTTEKATDVMAAGYQKVKS------AYQSAFGIAAIGAAAVKGAQMASELQNQYKT-TFNLLVTGGEQAKEAQENVNKMQEQGSELSVKYGKTQKE----TSSQALAALPTMLQASVASGDDFTDVVHNSTAALESFGMRSNDVAGMTKNTKEAVNQMAYAADMTATDFQNMGAMEYVGASAHQSKLSLSETASAIGILSNNGLEA----DKAGTGLRKVIVSLQSPSKDAAEA--------LSGIGLSTKDFVDQNGNMKSMEIFGLLNQHTEKLSSFQKGQ........... |
523 |
5 | -11.200 | [NT] COG0840 Methyl-accepting chemotaxis protein |
ali follow.. |
8 | 124 | ...................................................................................................................................................................................................................................................................................................................................................................................................................DGLRKNADSILASEQTVLSLHQVASTLAETIPQLQVEYEEVVDILLENGAPADQVAVAQRQSLERILGSVNKVLAGDENSVQAADSFGRDASLFGRVLKGMQEGNAAMSISKVTNAEAVDRLNEIAE------LFEFVSGSVDEILETSPDLFQVREAANNIFSVSQTLLDKASQLADGFENLAGGRSINLFAGYALGALALASIILIGLVMVRETNRRLAETAEKNDRNQAAILRLLDEIADLADGDLTVAATVTEDFTGAIADSI------------NYSIDQLRELVETINQTAVQVAAAAQETQSTAMHLA-EASEHQAQEIAGASAAINEMAVSIDQVSANASESSAVAERSVAIANKGNEVVHNTITGMDNIREQIQDTSKRIKRLGESSQEIGDIVSLINDIADQTNILVVADEVQAERSSAATKQIEALVKTIQTDTNEAVISMEQTTSEVVRARLAQDAGVALEEIEKVSKTLAALIQNISNAARQQASSAGHISNTMNVIQEITSQTS |
646 |
6 | -10.700 | [S] COG5280 Phage-related minor tail protein |
ali follow.. |
10 | 3 | ....................................................................................................................................................................................................................................................................................................................................................................................................................................KKISGITIAIGADTTGVTNGLKDIGKQSNSVNSELRDVERLLKLNPNNVELVAQKQQLLSKQVELTTKKLDGLKGAQADVDRQFKSGDIGEEQYRAFQRE--------------------VVATEGRLDHYKQSLKDVESSSGEAGNATKGLGGKFDELGQSVEDVG---EAVKGGVLMEAADHLSVVGDKLKEFSGSAQEAFSDVDEGMDKITTTTGKASDEFKTQFDNIISSMAVDSFEDVGSALGTLSAQFDMSGDTLEKNSKLALQYANTDVKTSIESAKSAIEAYGLSNKDFS-TVLDSVTATSQRTGVAVDSLFDSAVKGAPQIKDLG----NFSQGTELLGQFSKAGVDGDAALSSLSKASIIYAKGNKSLSEGLGETIEKIKNAKTKQEALTEAATV----GTKGASRMVDAIQRGAFNLSELGDVAKKSNGTISDTFNKTVDDIDEQQIASQQAKVAMSEFAIATGLKPLLDLLVPL............... |
463 |
7 | -10.700 | [D] COG3096 Uncharacterized protein involved in chromosome partitioning |
ali follow.. |
10 | 223 | ...................................................................................................................................................................................................................................................................................................................................................PENSGVRKAFQDMEAALRENRMTLEAIR-VTQSDRDLFKHLISEATNYVAADYMRHANERRVHLDKALEFRRELHTSRQQLAAEQYKHVDMARELAEHNGAEGDLEADYQAASDHLN-LVQTALRQQEKIERYEADLDELQIRLEEQNEVVAEAIERQQENEARAEAAELEVDELKSQLADYQQALDVQ---QTRAIQYNQAIAALNRAKELCHLPDLTADCAAEWLETFQAKELEATEKMLSLEQKMSMAQTAHSQFEQAYQLVVAINGPLARNEAWDVARELLREGVDQRHLAEQVQPLRMRLSEEQRLREQQEAERLLADFCKRQGKNFDIDEL--EALHQELEARIASLSDSVSNAREERMAL--RQEQEQLQSRIQSLMQRAPVWLAAQNSLNQL---SEQCGEEFTSSQDVTEYLQQLLERERE----AIVERDEVGARKNAVDEEIERLSQPGGSEQRLNALAERFGG---VLLSAPYFSA-RHAIVVPDLSQVTEHLEGLTDCLIESFDDSVFSVDELEKAVVVKIADRQWRYSRFESRIESLHAEREIRQLNSRRVELERALSNHENDNQQ.. |
861 |
8 | -10.400 | [S] COG1511 Predicted membrane protein |
ali follow.. |
8 | 71 | ..................................................................................................................................................................................................................................................................................................................................................................................................................DDLVKELKDNNNFDWHFSNDLDQSLKDLLNKYYLVVEIPEDFSKNASTVLDKNPKKLDLKYHTNAGSNYVGATIGEKAIDKLKASVSKEVTEQYTKVIFDNFKDIAKGLSDASSGAKKIDDGTKDAKNKENLAKLKESTATISDKTAQLADGAAQVTSGIQSLDSSLGKFQDSSNQIYDKSSQLAAGSGELTSKMNELLAGLQNV--QKGTPNLTNGLDQLNSKVQEGSEKAAKAEKIINALDLTKLETAVNNLEKSETAMKEFKKQLTDFENSLKNRDQA-FKNVINSSDFLTAEQKSQLINSVEKKLPQVDAPDFDQIQLPTADQLPDIATIKSSLEDVKAQVAQVKAMPEATSKLYNGAKTIQDAIDRLTEGADKIYNGSQKLTDGQTKLTAGNKQFAKAKAGSEQLVTGSSQVLFKLLDGSKQVQSGSSKLADGSASLDTGLGKLLDGTGELSSKLKDAA----DQTGDIDADDQTYGMFADPVKTKDD.......................... |
571 |
9 | -10.200 | [R] KOG4678 FOG: Calponin homology domain |
ali follow.. |
10 | 28 | ...........................................................................................................................................................................................................................................................................................................................................................................REFSVTVSRERSVPRGPSNPRKSVSSPTSSNTPTPTKHLRTPSTKPKQENEGGEKAASQVRELLAEAKAKDSEINRLRSELKKSPGDTEPMIRALEEKNKNFQKELSDLEEENRVLKEKLIYLEHSPNSEGAASHTGDSSCPTSITQESSFGSPTGNQMSSDIDEYKKNIHGNALRTSGSSSSDVTKASLSPDASDFEHITAETPSRPLSSTSNPFKSSKCSTAGSSPNSVSELSLAS--LTEKIQKMEENHHSTAEELQATLQELSEKLVDEKTILETSFHQHR--ERAEQLSQENEKLMNLL-------------QERVKNEEPTTQEGKIIELEQKCTGILEQGRFE--------REKLLNIQQQLTCSLRKVEEENQGALEMLKEENEKLNEFLELERHNNNMMAKTLEECRVTLEGLKSHLQGEKQKATESCEVQEMLKVARA-CNELRQELLKANGEIKHVSSLLAKVEKDYSYLKEICDHQAEQLSRTSLKLQEKASESDAEIKDMKETIFELEDQVEISELESSVIKLEEQKSDLERQLKTLTKQMKEET |
637 |
10 | -9.900 | [S] COG5412 Phage-related protein |
ali follow.. |
9 | 80 | ...................................................................................................................................................................FDRLVGIDSARAKLKGLGHDAEAIDSIMDSALASVKGTAFLDEAATTAANAVAAGIPPGKEL-TRYLSLTADTAAIAGTSLGEIGAILNKVTTSGRA-ELQMLSDRGLPVYQWLAEEANTT-----ADAIFDMASKGEISTDMLLNAIEKNIGGAAKIMGEESFSAAIANIGADIARIGANFLDAGGKAGGFFSTVKPLLTEFRGFLAQVEEQAADWGVAFGQAFNNVIDRVRELKSWFDGLSPSVQTLITRAVAIGAGFLVGIGPALKVVGFLTTQFGSLLNITSLLLSPIGLVVVGITGLAVAFGVAMAKSEEFRNLVFGVFQNLASIISTIATVSPILQTMWDGAREGLASFAETVGGRLINAFELIVTVLQTVVVAVTEFVSSFIQGFQSAGGEVTSLSSLFLGFNPVLSMALLILQEFGPQIAQGFSQIASMALPLLTMLGQTLGELAAAIIPMVMNVISALMPVVMSLGMTIMDLAMAIIPILIDVFSQLLPIITQLVTTFAGIIAQVAPLVTILVSETVLNIVQAVAPALIAILGAVASAFDAIIPVVMAVLSTVVNVVANIISAISPIVAFVAGIISSIIS--------SPIVTFIAGIISSIFSVISPITSFVSGVFSTVFSIISG---FRNILGTVTSAIRTVSSIISSLS---GVVSGVFNRIFSIASSIMNRVSSVITGVFNAIQSSWTGLTSFVSGVGIGNAVQRLVNQVKSFV--NGVISGINAAIGLINK............. |
821 |
11 | -9.260 | [F] KOG2056 Equilibrative nucleoside transporter protein |
ali follow.. |
17 | 1 | MSISTIRRQ---SDAQVKVREATSNDPWGPSTALMSEIADLTHNPMAFTEIMSIVWKR---KNWRHVYKSLVLLDFLIKCGHEKVAQQCRENVFTIETLKDFQHVEDNRDQGLNIREKAKQIDERLKNERT...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
144 |